Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis
Two-Year Data from MERCURY Study Presented at AOSSM-AANA Combined 2021 Annual Meeting
World’s First “Artificial Meniscus” Available in Israel
Active Implants Receives FDA Breakthrough Device Designation for NUsurface® Meniscus Implant
Final Patient Treated in Clinical Trials for Active Implants’ NUsurface® Meniscus Implant
100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface® Meniscus Implant
Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface® Meniscus Implant
Active Implants LLC Appoints Charles W. Federico and Gary D. Henley to Board of Managers
TOCA (The Orthopedic Clinic Association) Performs First Meniscus Replacements in Arizona with NUsurface® Meniscus Implant
OrthoIndy Performs First Meniscus Replacements in Indiana with NUsurface® Implant
Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego
OrthoMemphis Performs First Meniscus Replacement in Tennessee with NUsurface® Implant
Advanced Orthopedics & Sports Medicine Specialists Performs FirstMeniscus Replacements in Colorado with NUsurface® Meniscus Implant
Active Implants LLC Secures First Tranche of a $40 Million Equity Financing
Active Implants Appoints Ted Davis President and Chief Executive Officer
Arlington Orthopedic Associates, P.A. Performs First Meniscus Replacements in Texas with NUsurface® Meniscus Implant
Capital Regional Orthopaedic Associates Performs First Meniscus Replacements in New York with NUsurface® Implant
Sports Medicine Oregon Performs First Meniscus Replacements in Oregon with NUsurface® Implant
Baton Rouge Orthopaedic Clinic Performs First Meniscus Replacement in the South with NUsurface® Implant
Salt Lake Regional Medical Center First in the U.S. to Perform Meniscus Replacement to Relieve Persistent Knee Pain in SUN Clinical Trial
Advanced Orthopaedics Performs Virginia’s First Meniscus Replacement with NUsurface® Implant
Active Implants’ VENUS Clinical Trial for Persistent Knee Pain Now Underway in Memphis
VENUS Clinical Trial for Persistent Knee Pain Now Underway in North Carolina
Active Implants Initiates Second Clinical Trial Evaluating NUsurface® Meniscus Replacement
VENUS Clinical Trial for Persistent Knee Pain Now Underway in Indiana
VENUS Clinical Trial for Persistent Knee Pain Now Underway in New York City
First NUsurface® Meniscus Implant Implanted in the US for Early Knee Osteoarthritis
U.S. Food & Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to conduct a pivotal clinical trial of the NUsurface® Meniscus Implant for early Knee Osteoarthritis
Active Implants LLC Closes $26.0 Million Financing Round
NUsurface® Meniscus Clinical Trial Reaches Key Milestone
Active Implants Corporation Announces Appointment of New President
$10 MM Convertible Debt to Focus on Clinical Study
Active Implants Announces CE Class III Medical Device Approval
Active Implants Corporation Names New Chief Financial Officer
Active Implants Corporation Closes $10 Million in Financing and Announces New Board Director
Active Implants Enters Agreement with UK Company
Active Implants, InMotion Forge New Partnership Relationship Expands Active Implants Research Capabilities In Advanced Polymers In Orthopedics
Active Implants Corporation Announces CE Mark Approval for Novel Low Wear, Polymer Hip Implant
Active Implants Corporation Announces Vice President Orthopedic Research
Active Implants(TM) Corporation Clinicals Begin on Innovative, Polymer Hip Implant; Early Intervention Orthopedic Company Reaches $10 million Funding Milestone
Early Intervention Orthopedic Company Reaches $10 million Funding Milestone
Active Implants Corporation Announces Funding Milestone and Creation of Board and Management Team
